Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 009561

Expand all

HYPAQUE (DIATRIZOATE SODIUM)
25%
Marketing Status: Discontinued

Active Ingredient: DIATRIZOATE SODIUM
Proprietary Name: HYPAQUE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 25%
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N009561
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: GE HEALTHCARE
Marketing Status:  Discontinued
Patent and Exclusivity Information

HYPAQUE (DIATRIZOATE SODIUM)
50%
Marketing Status: Discontinued

Active Ingredient: DIATRIZOATE SODIUM
Proprietary Name: HYPAQUE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 50%
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N009561
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: GE HEALTHCARE
Marketing Status:  Discontinued
Patent and Exclusivity Information

HYPAQUE SODIUM 20% (DIATRIZOATE SODIUM)
20%
Marketing Status: Discontinued

Active Ingredient: DIATRIZOATE SODIUM
Proprietary Name: HYPAQUE SODIUM 20%
Dosage Form; Route of Administration: SOLUTION; URETERAL
Strength: 20%
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N009561
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: GE HEALTHCARE
Marketing Status:  Discontinued
Patent and Exclusivity Information